Lin CC - Search Results

1

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis.

Liao BC, Lee JH, Lin CC, Chen YF, Chang CH, Ho CC, Shih JY, Yu CJ, Yang JC. Liao BC, et al. Among authors: lin cc. J Thorac Oncol. 2015 Dec;10(12):1754-61. doi: 10.1097/JTO.0000000000000669. J Thorac Oncol. 2015. PMID: 26334749 Free article.

2

Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.

Pu YS, Hsieh MW, Wang CW, Liu GY, Huang CY, Lin CC, Guan JY, Lin SR, Hour TC. Pu YS, et al. Among authors: lin cc, lin sr. Biochem Pharmacol. 2006 Mar 14;71(6):751-60. doi: 10.1016/j.bcp.2005.12.009. Epub 2006 Jan 18. Biochem Pharmacol. 2006. PMID: 16413505

3

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.

Lin ZZ, Hsu C, Chang YC, Yu CJ, Hsu CH, Lin CC, Cheng AL, Yang PC, Yang CH. Lin ZZ, et al. Among authors: lin cc. Lung Cancer. 2008 May;60(2):215-21. doi: 10.1016/j.lungcan.2007.10.002. Epub 2007 Nov 19. Lung Cancer. 2008. PMID: 18022277 Clinical Trial.

4

Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.

Hsu FM, Lin CC, Lee JM, Chang YL, Hsu CH, Tsai YC, Lee YC, Cheng JC. Hsu FM, et al. Among authors: lin cc. J Surg Oncol. 2008 Jul 1;98(1):34-41. doi: 10.1002/jso.21063. J Surg Oncol. 2008. PMID: 18449912 Clinical Trial.

5

Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.

Hsu C, Kuo SH, Hu FC, Cheng AL, Shih JY, Yu CJ, Lin CC, Huang TC, Yang PC, Yang CH. Hsu C, et al. Among authors: lin cc. Lung Cancer. 2008 Dec;62(3):334-43. doi: 10.1016/j.lungcan.2008.03.010. Epub 2008 May 2. Lung Cancer. 2008. PMID: 18450322 Clinical Trial.

6

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer.

Lin CC, Yang CH. Lin CC, et al. Target Oncol. 2009 Jan;4(1):37-44. doi: 10.1007/s11523-009-0104-2. Epub 2009 Jan 20. Target Oncol. 2009. PMID: 19343300 Review.

7

Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.

Shao YY, Lin CC, Yang CH. Shao YY, et al. Among authors: lin cc. Discov Med. 2010 Jun;9(49):538-45. Discov Med. 2010. PMID: 20587343 Free article. Review.

8

Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.

Lin CC, Hsu HH, Sun CT, Shih JY, Lin ZZ, Yu CJ, Chen GG, Hsin MK, Lam KC, Leung L, Yang CH, Mok T. Lin CC, et al. Among authors: lin zz. J Thorac Oncol. 2010 Sep;5(9):1424-9. doi: 10.1097/JTO.0b013e3181e9db73. J Thorac Oncol. 2010. PMID: 20631634 Free article.

9

Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations.

Lin CC, Yang JC. Lin CC, et al. Drugs. 2011 Jan 1;71(1):79-88. doi: 10.2165/11587560-000000000-00000. Drugs. 2011. PMID: 21175241 Review.

10

Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.

Lee JM, Yang SY, Yang PW, Shun CT, Wu MT, Hsu CH, Lin CC, Cheng JC, Wang YH, Chuang TH, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC. Lee JM, et al. Among authors: lin cc. Ann Surg Oncol. 2011 Jul;18(7):2066-73. doi: 10.1245/s10434-011-1559-9. Epub 2011 Feb 5. Ann Surg Oncol. 2011. PMID: 21298351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,904 results

Search Page

Filters